Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix C E Vogel

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature Cancer|January 25, 2024
Lipids as mediators of cancer progression and metastasisFelix C E Vogel, Adriano B Chaves-Filho, Almut Schulze
Cold Spring Harbor Perspectives in Medicine|July 1, 2024
Interactions of Fatty Acid and Cholesterol Metabolism with Cellular Stress Response Pathways in CancerAlina M Winkelkotte, Kamal Al-Shami, Adriano B Chaves-Filho, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 7, 2020
Zelkovamycin is an OXPHOS Inhibitory Member of the Argyrin Natural Product FamilyDaniel Krahn, Geronimo Heilmann, Felix C E Vogel, et al.
The Journal of Investigative Dermatology|June 24, 2019
Targeting the H3K4 Demethylase KDM5B Reprograms the Metabolome and Phenotype of Melanoma CellsFelix C E Vogel, Natalie Bordag, Elmar Zügner, et al.
Cell Death and Differentiation|May 18, 2023
USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancerCarina R Maier, Oliver Hartmann, Cristian Prieto-Garcia, et al.
Nature Metabolism|January 20, 2025
Targeting aldolase A in hepatocellular carcinoma leads to imbalanced glycolysis and energy stress due to uncontrolled FBP accumulationMarteinn T Snaebjornsson, Philipp Poeller, Daria Komkova, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2023
p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cellsOri Hassin, Miriam Sernik, Adi Seligman, et al.
JCO Precision Oncology|September 11, 2020
Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic MelanomaRenáta Váraljai, Kilian Wistuba-Hamprecht, Teofila Seremet, et al.
Cell Death and Differentiation|May 26, 2026
Fatty acid channelling into triglycerides and oxylipins drives ferroptosis resistance during oncogenic BRAF-induced senescenceMarkus S Hess, Kamal M Al-Shami, Carolina Dehesa Caballero, et al.
EMBO Molecular Medicine|July 12, 2023
LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastomaHamed Alborzinia, Zhiyi Chen, Umut Yildiz, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature Cancer|January 25, 2024
Lipids as mediators of cancer progression and metastasisFelix C E Vogel, Adriano B Chaves-Filho, Almut Schulze
Cold Spring Harbor Perspectives in Medicine|July 1, 2024
Interactions of Fatty Acid and Cholesterol Metabolism with Cellular Stress Response Pathways in CancerAlina M Winkelkotte, Kamal Al-Shami, Adriano B Chaves-Filho, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 7, 2020
Zelkovamycin is an OXPHOS Inhibitory Member of the Argyrin Natural Product FamilyDaniel Krahn, Geronimo Heilmann, Felix C E Vogel, et al.
The Journal of Investigative Dermatology|June 24, 2019
Targeting the H3K4 Demethylase KDM5B Reprograms the Metabolome and Phenotype of Melanoma CellsFelix C E Vogel, Natalie Bordag, Elmar Zügner, et al.
Cell Death and Differentiation|May 18, 2023
USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancerCarina R Maier, Oliver Hartmann, Cristian Prieto-Garcia, et al.
Nature Metabolism|January 20, 2025
Targeting aldolase A in hepatocellular carcinoma leads to imbalanced glycolysis and energy stress due to uncontrolled FBP accumulationMarteinn T Snaebjornsson, Philipp Poeller, Daria Komkova, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2023
p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cellsOri Hassin, Miriam Sernik, Adi Seligman, et al.
JCO Precision Oncology|September 11, 2020
Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic MelanomaRenáta Váraljai, Kilian Wistuba-Hamprecht, Teofila Seremet, et al.
Cell Death and Differentiation|May 26, 2026
Fatty acid channelling into triglycerides and oxylipins drives ferroptosis resistance during oncogenic BRAF-induced senescenceMarkus S Hess, Kamal M Al-Shami, Carolina Dehesa Caballero, et al.
EMBO Molecular Medicine|July 12, 2023
LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastomaHamed Alborzinia, Zhiyi Chen, Umut Yildiz, et al.
Pageof 2